Orocal

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Orocal

Property Description
Active ingredient Calcium Carbonate
Form Oral tablet, Chewable tablet
Pharmacological class Mineral Supplement, Calcium Metabolism Regulator
Common use Correcting dietary calcium shortfalls
Origin Derived mineral substance

The Identity and Classification of Orocal

Orocal is a pharmaceutical preparation whose primary active ingredient is Calcium Carbonate, classified as a Mineral Supplement and an antacid. It functions as a Calcium Metabolism Regulator, a role important for supporting systemic mineral balance. The active substance, Calcium Carbonate, is utilized to manage conditions related to low calcium levels and is categorized as a calcium supplement, antacid, and phosphate binder.

The Orocal product is primarily formulated as a monocomponent oral preparation, although it is frequently presented in a combined form, such as with Vitamin D, a critical nutrient that enhances the absorption and efficient utilization of the calcium salt.

Composition, Forms, and Origin of the Medicine

The core composition is the highly purified Calcium Carbonate, supplied for oral administration most commonly as a tablet or chewable tablet. This focus on the chewable form often caters to individuals who experience difficulty swallowing traditional tablets. As a substance, Calcium Carbonate is a derived mineral substance that is prepared to meet pharmaceutical standards.

Orocal is formulated to deliver a precise amount of elemental calcium per dose, which is the biologically active component. The final solid dosage form consists of the active ingredient integrated with solid preparation excipients, binders, and flavorings that facilitate the manufacturing of a stable and palatable oral product.

General Purpose: Why is Orocal Used?

The general purpose of taking Orocal is to correct dietary shortfalls and ensure the maintenance of adequate, regulated calcium levels within the body. By providing this critical element, the product supports the fundamental integrity of the skeletal system, which includes the continuous process of bone mineralization. A common, neutral use scenario involves supplementing the diet of patients who cannot achieve sufficient calcium intake through food alone. A notable secondary function of Calcium Carbonate is its ability to neutralize gastric acid by acting as a buffer in the stomach's acidic environment, providing a functional benefit beyond purely mineral supplementation.

Regulatory References

  1. NIH StatPearls: Calcium Carbonate

What side effects are possible with Orocal?

The safety profile of Orocal is primarily associated with its components, commonly Calcium Orotate and/or a Bisphosphonate like Ibandronic Acid, and is structured around gastrointestinal events and systemic calcium regulation.

Common Adverse Reactions

Adverse reactions that are frequently reported (common) often involve the gastrointestinal system and include:

  • Bloating and abdominal swelling.
  • Constipation, nausea, vomiting, and diarrhea.
  • Upset stomach or dyspepsia.
  • Musculoskeletal symptoms such as back pain, joint pain (arthralgia), and muscle pain (myalgia).

Serious and Clinically Significant Safety Concerns

The most serious reported risks relate to metabolic imbalances and gastrointestinal complications:

  • Hypercalcemia (high calcium levels in the blood) and Hypercalciuria (high calcium levels in the urine), which can lead to the formation of kidney stones.
  • Severe upper gastrointestinal adverse events, including irritation and ulceration of the esophagus, especially if the bisphosphonate component (if present) is not administered strictly according to label instructions.
  • Severe, and occasionally incapacitating, bone, joint, and/or muscle pain has been reported with bisphosphonate therapy.

Safety Restrictions and Contraindications

Orocal is officially contraindicated in patients with:

  • Pre-existing high blood calcium levels (hypercalcemia).
  • Severe renal impairment (Creatinine Clearance <30 ml/min is a restriction for the bisphosphonate component).
  • Known allergies or hypersensitivity to any ingredient.
  • Conditions affecting esophageal emptying (if the bisphosphonate component is included).

Important Safety Monitoring Notes

Monitoring of serum calcium and calcifediol levels is often noted in regulatory documents. The potential for drug interactions is high; the absorption of several medications, including certain antibiotics and levothyroxine, can be reduced by calcium and multivalent cations. The bisphosphonate tablet must be taken separately from all food, beverages (except plain water), and other medications for at least 60 minutes.

Overdose and Emergency Response

Overdose and when to seek help

The information below outlines the officially documented presentations of overdose and the required emergency actions as stated in regulatory prescribing information.

Overdose with Calcium Carbonate, the active ingredient in Orocal, is primarily characterized by the development of hypercalcemia (excessive calcium in the blood) and hypercalciuria (excessive calcium in the urine).

Documented Overdose Manifestations

System Official Manifestations (as documented)
Gastrointestinal Nausea, vomiting, constipation, abdominal pain, loss of appetite (anorexia).
Systemic/CNS Polydipsia (excessive thirst), polyuria (excessive urination), muscular weakness, confusion, continuous headache, or depression.
Severe Outcomes Renal insufficiency/damage, Milk-Alkali Syndrome, serious heart rhythm disturbances, and coma.

Emergency Actions and Seeking Urgent Help

The regulatory guidance is explicit that users must seek immediate medical attention or consult a doctor immediately if an overdose is suspected or if more than the recommended dosage has been taken. Contacting a Poison Control Center is also mandated. The official first step in management is the immediate discontinuation of the product.

Treatment of an officially documented overdose is supportive and symptomatic, focusing on reducing serum calcium levels and maintaining hydration. Patients with underlying kidney impairment are documented to have an increased risk of severe outcomes, which necessitates continuous monitoring of renal function and serum calcium.

Therapeutic Uses of Orocal

Quick Facts: Orocal Therapeutic Use

  • Supports the management of calcium and vitamin D deficiencies.
  • Used as a supportive treatment alongside specific osteoporosis management.
  • Intended to maintain acceptable levels of calcium and Vitamin D in individuals with identified deficiencies.

Orocal is a pharmaceutical product primarily indicated for addressing combined deficiencies of calcium and Vitamin D3 (cholecalciferol) in adults and older patients. The medication is utilized to help restore and maintain appropriate levels of these essential nutrients within the body. Maintaining adequate calcium and Vitamin D levels supports bone health and metabolism.

Furthermore, this medication is frequently employed as a necessary adjunct to other established treatments for osteoporosis. The intent of this supplementary use is to provide the required nutritional input of calcium and Vitamin D that may be insufficient from dietary sources alone, thereby supporting the primary therapeutic strategy for managing bone density loss. This approach is utilized for calcium and Vitamin D combinations.

Eligibility and Restrictions for Use

Official Eligibility for Orocal Use

Orocal (Calcium Carbonate and Colecalciferol) is officially permitted for adults and older patients for the prevention and treatment of combined calcium and Vitamin D deficiencies, and as an adjunct to specific osteoporosis treatments. Eligibility is strictly defined by regulatory authorities based on a patient's underlying conditions, particularly those affecting calcium metabolism and kidney function.

Absolute Contraindications

Use is contraindicated and the medicine must not be used in populations with the following conditions:

  • Hypercalcaemia or Severe Hypercalciuria (high levels of calcium in the blood or urine).
  • Severe Renal Failure or Severe Renal Impairment.
  • Nephrolithiasis (kidney stones) or Hypervitaminosis D (Vitamin D overdose).
  • Diseases associated with high calcium levels, such as sarcoidosis, myeloma, or bone metastases.
  • Hypersensitivity to the active substances or excipients.

Restricted and Age-Related Use

Population Group Regulatory Status
Children and Adolescents Not recommended due to high Vitamin D content and lack of established indication.
Pregnancy/Lactation Conditional use only under physician supervision with strict limits on total daily intake.
Mild/Moderate Renal Impairment Use with caution; requires careful supervision and monitoring of renal function and calcium levels.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Orocal (Calcium Carbonate) exhibits officially documented interactions categorized by their effect on drug exposure and systemic balance, as defined by regulatory agencies.

Pharmacokinetic Interference (Reduced Absorption)

The most common type of interaction is pharmacokinetic, where calcium physically binds to certain medicines in the digestive tract, resulting in a reduced systemic exposure of the co-administered drug. This mechanism affects:

  • Antibiotics: Such as Tetracyclines and Fluoroquinolones, whose absorption is significantly impaired by calcium chelation.
  • Thyroid Hormones: Specifically Levothyroxine, where calcium reduces its absorption and efficacy.
  • Bone Agents: Including Bisphosphonates, whose bioavailability is lowered by concurrent calcium intake.
  • Iron Supplements also face reduced absorption due to chelation.

To prevent this reduction in drug concentration, regulatory labels mandate mandatory timing separation. For instance, co-administration with tetracycline antibiotics requires separation by at least four to six hours, and Levothyroxine requires at least four hours separation.

Pharmacodynamic Risk (Systemic Effects)

The official profile also notes pharmacodynamic interactions related to calcium and Vitamin D's effect on systemic balance:

  • Cardiac Glycosides (e.g., Digoxin): Co-administration can heighten the risk of severe cardiac arrhythmias by potentiating the glycoside’s effects on the heart.
  • Thiazide Diuretics: These medicines decrease calcium excretion, increasing the risk of hypercalcaemia (excess calcium in the blood).

Population-Specific Cautions

Regulatory documents highlight that interaction severity is heightened in certain groups, such as elderly patients and those with renal impairment, where hypercalcaemia and impaired clearance increase risk.

Mechanism of Action

Orocal is a formulation containing calcium carbonate and cholecalciferol (Vitamin D3). The mechanistic action involves two separate components targeting systemic calcium homeostasis.

Calcium Carbonate

Orally administered calcium carbonate dissociates in the gastrointestinal lumen, releasing calcium ions ( Ca^2+). These Ca^2+ ions are absorbed primarily in the small intestine via active transport, which is facilitated by calcitriol (the active metabolite of Vitamin D3), and through passive diffusion. Once absorbed, the Ca^2+ enters the systemic circulation, contributing to the total serum calcium pool. Increased serum Ca^2+ modulates the parathyroid gland's calcium-sensing receptor (CaSR), leading to a reduction in parathyroid hormone (PTH) secretion. PTH acts to increase bone resorption and renal calcium reabsorption; therefore, its systemic reduction modulates the net turnover of calcium in bone and kidney tissue.

Cholecalciferol (Vitamin D3)

Cholecalciferol, an inactive precursor, is metabolized in the liver to calcidiol and subsequently in the kidney to the biologically active calcitriol (1,25( OH)2 D3). Calcitriol functions as an agonist for the nuclear Vitamin D Receptor (VDR) in target cells, including intestinal enterocytes and osteoblasts. VDR activation upregulates the transcription of proteins, such as the Ca^2+-transporting channel TRPV6 and the calcium-binding protein calbindin-D9k, which collectively increase the efficiency of intestinal Ca^2+ absorption. This molecular pathway provides the direct control mechanism for augmenting systemic Ca^2+ availability from the diet, supporting the maintenance of serum calcium concentration.

Dosage and Administration Information

How Orocal is Used: Administration Guidelines

The usage instructions for Orocal, which contains the active ingredient Calcium Carbonate, involve a standardized oral administration protocol. This medicine is provided as chewable or suckable tablets, which must be completely dissolved or chewed prior to swallowing, and is not meant to be ingested whole.


Dosing and Frequency

Administration Scope Instruction
Route of Administration Oral route only. The product is administered via the mouth.
Standard Adult Dose A typical regimen involves 500 mg to 1500 mg of elemental calcium per day, often corresponding to 1 to 3 tablets of the 500 mg elemental calcium strength.
Timing and Frequency The total daily dose is commonly administered as a divided dosage (e.g., once or twice daily) and is directed to be taken with or immediately after a meal.
Pediatric Use Specific, reduced daily dosages are outlined for children and adolescents to address calcium deficiency, with the required dose depending on age and weight.

Procedural Conditions

For continuous or long-term administration, protocols include regular monitoring of calcium levels in the blood and urine to ensure appropriate usage and prevent accumulation. If a scheduled dose is missed, it is generally recommended that it should be taken as soon as remembered, unless it is nearly time for the next dose, in which case the missed dose should be omitted.

Recent Clinical Evidence

Orocal: Recent Clinical Evidence

Clinical research on Orocal, which contains Calcium Carbonate and Colecalciferol (Vitamin D3), focuses primarily on its role in bone health. This combination is widely studied for preventing and treating conditions associated with low calcium and Vitamin D levels, such as bone loss (osteoporosis) and decreased activity of the parathyroid gland.


Primary Efficacy Outcomes

Studies examine the impact of calcium and Vitamin D supplementation on bone mineral density (BMD) and fracture risk, particularly in postmenopausal women. The evidence suggests that consistent supplementation with calcium and Vitamin D may be associated with improved BMD, especially in the lumbar spine.

  • Bone Mineral Density (BMD): Research indicates that the combination helps maintain adequate serum calcium levels, which are essential for bone homeostasis. Studies have shown BMD changes over time when compared to placebo groups, with variations based on the skeletal site measured.
  • Long-Term Follow-up: Ongoing research tracks the long-term effects of this supplementation on reducing the incidence of fractures in various high-risk populations.

Safety and Subgroup Data

Clinical trials have evaluated the supplement's use across different patient groups, including those with pre-existing conditions, to ensure a comprehensive safety profile. The primary safety concerns reported in studies relate to gastrointestinal effects.

Adverse Events (Reported in Trials) Population
Constipation, flatulence, nausea Wide patient population
Increased risk of hypercalcemia (high calcium levels) Patients with impaired kidney function or high dose use

Mechanism of Action Focus

Calcium is a key component for the proper function of nerves, cells, and bone structure. Vitamin D3 is essential as it facilitates the absorption of calcium in the small intestine, thus playing a vital role in maintaining the body's calcium balance.

Frequently Asked Questions (FAQ)

Common questions about Orocal (FAQ)


Q: How quickly does Orocal start to work?

The active components of Orocal are absorbed over a few hours following administration. Studies have indicated that the elevation of circulating calcium levels in the blood can be observed within several hours after a dose. However, the full homeostatic effect on long-term bone health is achieved over an extended duration of use.


Q: What are the most common side effects reported for Orocal?

According to official product information, the most commonly reported adverse effects involve the stomach and digestive tract. These frequently include constipation, flatulence, nausea, vomiting, diarrhea, and general upset stomach (dyspepsia).


Q: Can Orocal cause stomach upset?

Yes, upset stomach or dyspepsia is listed in regulatory documents as a commonly reported adverse reaction. This is generally related to how the body processes the mineral components.

--UN

Q: Can Orocal cause constipation?

Constipation is noted in regulatory documents as one of the commonly reported adverse reactions associated with the use of the medicine’s active ingredients.


Q: What is the difference between Orocal and other calcium brands?

Official documents define Orocal by its specific active substances: Calcium Carbonate, often combined with Cholecalciferol (Vitamin D3). The specific form of the calcium salt and the inclusion of Vitamin D3 is what differentiates the product from supplements that may contain different types of calcium or a single active ingredient.


Q: How long can someone typically stay on Orocal?

The duration of use is determined by a health professional. For continuous or long-term administration, official protocols require regular monitoring of blood and urine calcium levels to ensure appropriate management of systemic calcium balance.


Q: Does Orocal affect blood pressure?

Official documents note that a pharmacodynamic interaction can occur with cardiac glycosides, heightening the risk of heart rhythm changes (arrhythmias). Further research also suggests a relationship between high-dose calcium ingestion and acute changes in blood pressure.


Q: What are the main risks associated with taking too much Orocal?

Taking amounts greater than recommended or using the medicine for too long can increase the risk of adverse reactions. The most significant risks involve hypercalcemia (excess calcium in the blood) and hypercalciuria (excess calcium in the urine).


Q: Is Orocal available over the counter?

The medicine is indicated for use under a health professional’s supervision. Instructions in official documents direct the user to strictly comply with the doctor’s prescription, suggesting regulated use.


Q: Can Orocal be taken alongside mineral supplements like iron or zinc?

Official documents note that the calcium salts in Orocal may reduce the absorption of both iron and zinc supplements. Regulatory information notes that a time separation of at least two hours between taking these supplements and Orocal is advised in official documentation.


Q: Does taking Orocal affect liver function?

While severe renal (kidney) impairment is a contraindication, the active Vitamin D3 component must undergo initial metabolism in the liver to become active. Liver function is not typically listed as a primary monitoring requirement in the same way kidney function is.


Q: Is Orocal the same as generic calcium supplements?

The primary active ingredient in Orocal is calcium carbonate, which is a generic mineral substance. Orocal is a brand-name formulation containing this ingredient, and is often manufactured in combination with Vitamin D3.


Q: What should I do if I experience a rare side effect from Orocal?

Official regulatory information provides channels for reporting any side effects, including those not listed in the patient information leaflet, to a health professional or the national reporting system of their country.


Q: Are there common foods or drinks to avoid while taking Orocal?

Official guidance notes the medicine is to be taken with or immediately after a meal. Calcium can bind (chelate) certain minerals found in foods, which may generally affect their absorption, but specific common food avoidance is not typically mandated in regulatory labeling.


Q: Is there scientific evidence supporting the use of Orocal?

Yes, clinical studies have examined the combination of calcium and Vitamin D3 (the components of Orocal) for its role in bone health and preventing deficiencies. The evidence suggests it may be associated with improved bone mineral density in certain populations.


Q: What is the recommended storage temperature for Orocal?

Official documents specify the product must be stored at a temperature not exceeding 30 C (or 25 C for blister packs) and protected from light and moisture.


Q: Is Orocal meant to prevent certain diseases?

Official indications state that Orocal is intended for the prevention and treatment of combined deficiencies of calcium and Vitamin D3. It is also used as an adjunct to specific osteoporosis treatments.


Q: Are there long-term safety concerns documented for Orocal?

For patients on continuous or long-term administration, regulatory protocols require regular monitoring of blood and urine calcium levels. This monitoring is mandated to manage the primary long-term risks of hypercalcemia and hypercalciuria.


Q: What is the usual duration of effect after taking Orocal?

The active component is absorbed over a few hours. Studies have indicated that the elevation of circulating calcium levels in the blood can be observed for several hours after taking a single dose.


Q: Is Orocal absorbed differently than plain calcium carbonate?

Orocal typically contains Vitamin D3 (Cholecalciferol), which actively facilitates the absorption of the calcium component in the small intestine. This process generally supports the absorption of the calcium component.


Q: What type of research has been done on Orocal?

The research supporting the use of the active components includes controlled clinical trials and long-term follow-up studies. These studies primarily focus on efficacy outcomes like bone mineral density (BMD) and the reduction of fracture risk in at-risk populations.


Q: Why is Orocal sometimes prescribed with other medications?

Official therapeutic indications include the use of Orocal as an adjunct, or additional, treatment to specific osteoporosis therapies. It is used this way when a patient’s dietary intake of calcium and Vitamin D3 is confirmed to be insufficient.


Q: Are there specific symptoms that warrant discontinuing Orocal?

Severe adverse events, particularly signs of hypercalcaemia (excess calcium in the blood) or hypercalciuria (excess calcium in the urine), often lead to the temporary or permanent discontinuation of the medicine as directed by a health professional.


Q: Does Orocal interact with certain types of antibiotics?

Yes, regulatory documents specifically note that interactions can occur with certain types of antibiotics, including tetracyclines and fluoroquinolones. The calcium component can reduce the antibiotic's systemic exposure if taken too closely together.


Q: Is there a maximum daily amount of Orocal that is described in official sources?

Official documents often define upper limits for total daily intake of elemental calcium from all sources, based on safety data. For example, specific regulatory guidance for use during pregnancy has a strict limit of 2,500 mg of elemental calcium per day.


Q: Are there warnings about driving or operating machinery while taking Orocal?

Official regulatory documents generally state that Orocal is not known to have an adverse effect on the ability to drive or operate machinery.


Q: Are there different forms of Orocal (e.g., tablet, chewable, liquid)?

The medicine is officially formulated for oral use, most commonly as a solid dosage form such as a tablet or a chewable/suckable tablet. Other forms, such as liquid, may not be defined in the official regulatory documentation.


Q: Is the efficacy of Orocal affected by age?

Official indications permit the use of Orocal for adults and older patients. Regulatory documents stress that age-related physiological changes can affect how medications are processed, which often necessitates careful supervision and monitoring.


Q: Why are people often told to take Orocal at a specific time of day?

Regulatory guidance notes the medicine is to be taken with or immediately after a meal. Taking the medicine with food can help aid the absorption of the calcium component and may also reduce the potential for gastrointestinal upset.


Q: Does Orocal contain synthetic ingredients?

The active component, Calcium Carbonate, is a derived mineral substance. The final product formulation includes various inactive components (excipients, binders, and flavorings) which are integrated with the active ingredient.


Q: Is Orocal considered a vitamin or a mineral supplement by regulators?

Regulatory authorities officially classify Orocal's primary active component as a Mineral Supplement (Calcium Carbonate). The product is often combined with Cholecalciferol, which is classified as Vitamin D3.


Q: Are there demographic groups where Orocal is not recommended?

Yes, official eligibility documents highlight specific groups. The medicine is not recommended for children and adolescents due to its Vitamin D3 content. It is also contraindicated in populations with pre-existing high blood calcium levels or severe renal (kidney) impairment.

How should Orocal be stored and disposed of?

The official storage and disposal requirements for Orocal (Calcium Carbonate/Cholecalciferol) are mandated to ensure the product’s quality and safe handling.

Official Storage Conditions

  • Temperature: The product must be stored at a temperature not exceeding 30 C (or 25 C for blister packs) and must be kept from freezing.
  • Protection: The medicine requires protection from light and moisture to maintain stability.
  • Packaging: It must be stored in the original container or carton. If stored in a bottle, the container must be kept tightly closed.
  • Child Safety: Like all medicines, it must be kept out of the sight and reach of children.

Disposal Instructions

Official instructions forbid disposal via wastewater or household waste. Unused or expired medication should be taken to a pharmacist or local collection point for proper pharmaceutical waste disposal, according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Orocal found in:

A-Z Index: